Inactive Instrument

Analyst Reco. Xenetic Biosciences Inc Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

Mar. 21	Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 18	CLS Therapeutics Discloses its Views on Xenetic Biosciences	CI

HC Wainwright Downgrades Xenetic Biosciences to Neutral From Buy	23-05-16	MT
HC Wainwright Adjusts Price Target on Xenetic Biosciences to $4 From $5, Reiterates Buy Rating	22-05-02	MT
XENETIC BIOSCIENCES : HC Wainwrigh Adjusts Xenetic Biosciences' Price Target to $5 From $2, Keeps at Buy	21-01-11	MT

No results for this search